Clinical Trial Update: Modulation of Cerebral Blood Flow Using Iron Chelators [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study evaluated using iron chelators to modulate cerebral blood flow. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Stroke, Problem of Aging | EARLY_Phase 1 | Status: COMPLETED